BioMed Research International / 2014 / Article / Tab 9

Research Article

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Table 9

IC50 values of potential drugs for early- and late-stage NSCLC.

Effect sizeStagecMap drug nameMTTClonogenic

ESEarlyMebendazole<1>10
Prenylamine>5>10
LateMebendazole<1>10
Spiperone>10<10
Anisomycin<0.1
Pyrvinium<0.1
Mefloquine>5
Niclosamide>5

value < 0.1EarlyTrichostatin A<1
Monensin<1
Cloperastine<10
LateTrichostatin A<1
Mefloquine>5
Pyrvinium<0.1
Securinine>5
Nortriptyline<10